Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model

Ahmad Tantawi Aktifanus, Ahmad Nazrun Shuid, Nurul Hashimah A Rashid, Tarn Heng Ling, Chua Yin Loong, Nurulhayati M. Saat, Norliza Muhammad, Norazlina Mohamed, Ima Nirwana Soelaiman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The standard treatment for postmenopausal osteoporosis is Estrogen Replacement Therapy (ERT) but it was associated with serious adverse effects such as breast cancer and cardiovascular disease. There is a need to find other alternatives for the treatment of post-menopausal osteoporosis. Vitamin E especially tocotrienol was shown to have anti-osteoporosis effects in many animal osteoporotic models but it has never been compared to estrogen. This study aimed to compare the effects of tocotrienol-enriched fraction to estrogen on the bone biochemical markers and dynamic histomorphometric changes using ovariectomised rats as the postmenopausal osteoporosis model. Thirty-two female Sprague-Dawley rats were randomly divided into groups of sham-operated (SHAM), ovariectomised control (OVC), ovariectomised+60 mg kg -1 tocotrienol-rich fraction (OV+T) and ovariectomised+64.5 μg kg -1 of premarin ® (OV+ERT). The rats were treated for two months and the serum osteocalcien and serum C-telopeptide of type 1 collagen (CTX) were measured using ELISA technique, while the femoral dynamic changes were analysed histomorphometric ally. The CTX levels were found to be lowered compared to the pre-treatment levels for all the groups. Only the osteocalcin level of OV+ERT group was significantly reduced compared to its pre-treatment level. Dynamic histomorphometric analysis showed that both the OV+ERT and OV+T groups have lower single-labeled surface/bone surface (sLS) but higher double-labeled surface/bone surface (dLS), bone formation rate/bone surface (BFR) and mineral apposition rate (MAR) compared to the BC and OVC groups. The OV+T group showed better effects on most of the dynamic parameters compared to the OV+ERT group. Therefore, in postmenopausal osteoporosis model, tocotrienol-rich fraction has shown better bone protective effects than ERT.

Original languageEnglish
Pages (from-to)225-234
Number of pages10
JournalAsian Journal of Animal and Veterinary Advances
Volume7
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

estrogen replacement therapy
Tocotrienols
tocotrienols
Postmenopausal Osteoporosis
Estrogen Replacement Therapy
osteoporosis
estrogens
Estrogens
animal models
bones
Bone and Bones
rats
conjugated estrogens
pretreatment
Conjugated (USP) Estrogens
menopause
osteocalcin
Breast Diseases
Osteocalcin
Therapeutics

Keywords

  • Bone biomarkers
  • Estrogen-deficiency
  • Histomorphometry
  • Osteoporosis

ASJC Scopus subject areas

  • veterinary(all)
  • Animal Science and Zoology

Cite this

Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model. / Aktifanus, Ahmad Tantawi; Shuid, Ahmad Nazrun; Rashid, Nurul Hashimah A; Ling, Tarn Heng; Loong, Chua Yin; Saat, Nurulhayati M.; Muhammad, Norliza; Mohamed, Norazlina; Soelaiman, Ima Nirwana.

In: Asian Journal of Animal and Veterinary Advances, Vol. 7, No. 3, 2012, p. 225-234.

Research output: Contribution to journalArticle

@article{cbb560c19043467aa1da7ba5b32e96b7,
title = "Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model",
abstract = "The standard treatment for postmenopausal osteoporosis is Estrogen Replacement Therapy (ERT) but it was associated with serious adverse effects such as breast cancer and cardiovascular disease. There is a need to find other alternatives for the treatment of post-menopausal osteoporosis. Vitamin E especially tocotrienol was shown to have anti-osteoporosis effects in many animal osteoporotic models but it has never been compared to estrogen. This study aimed to compare the effects of tocotrienol-enriched fraction to estrogen on the bone biochemical markers and dynamic histomorphometric changes using ovariectomised rats as the postmenopausal osteoporosis model. Thirty-two female Sprague-Dawley rats were randomly divided into groups of sham-operated (SHAM), ovariectomised control (OVC), ovariectomised+60 mg kg -1 tocotrienol-rich fraction (OV+T) and ovariectomised+64.5 μg kg -1 of premarin {\circledR} (OV+ERT). The rats were treated for two months and the serum osteocalcien and serum C-telopeptide of type 1 collagen (CTX) were measured using ELISA technique, while the femoral dynamic changes were analysed histomorphometric ally. The CTX levels were found to be lowered compared to the pre-treatment levels for all the groups. Only the osteocalcin level of OV+ERT group was significantly reduced compared to its pre-treatment level. Dynamic histomorphometric analysis showed that both the OV+ERT and OV+T groups have lower single-labeled surface/bone surface (sLS) but higher double-labeled surface/bone surface (dLS), bone formation rate/bone surface (BFR) and mineral apposition rate (MAR) compared to the BC and OVC groups. The OV+T group showed better effects on most of the dynamic parameters compared to the OV+ERT group. Therefore, in postmenopausal osteoporosis model, tocotrienol-rich fraction has shown better bone protective effects than ERT.",
keywords = "Bone biomarkers, Estrogen-deficiency, Histomorphometry, Osteoporosis",
author = "Aktifanus, {Ahmad Tantawi} and Shuid, {Ahmad Nazrun} and Rashid, {Nurul Hashimah A} and Ling, {Tarn Heng} and Loong, {Chua Yin} and Saat, {Nurulhayati M.} and Norliza Muhammad and Norazlina Mohamed and Soelaiman, {Ima Nirwana}",
year = "2012",
doi = "10.3923/ajava.2012.225.234",
language = "English",
volume = "7",
pages = "225--234",
journal = "Asian Journal of Animal and Veterinary Advances",
issn = "1683-9919",
publisher = "Academic Journals Inc.",
number = "3",

}

TY - JOUR

T1 - Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model

AU - Aktifanus, Ahmad Tantawi

AU - Shuid, Ahmad Nazrun

AU - Rashid, Nurul Hashimah A

AU - Ling, Tarn Heng

AU - Loong, Chua Yin

AU - Saat, Nurulhayati M.

AU - Muhammad, Norliza

AU - Mohamed, Norazlina

AU - Soelaiman, Ima Nirwana

PY - 2012

Y1 - 2012

N2 - The standard treatment for postmenopausal osteoporosis is Estrogen Replacement Therapy (ERT) but it was associated with serious adverse effects such as breast cancer and cardiovascular disease. There is a need to find other alternatives for the treatment of post-menopausal osteoporosis. Vitamin E especially tocotrienol was shown to have anti-osteoporosis effects in many animal osteoporotic models but it has never been compared to estrogen. This study aimed to compare the effects of tocotrienol-enriched fraction to estrogen on the bone biochemical markers and dynamic histomorphometric changes using ovariectomised rats as the postmenopausal osteoporosis model. Thirty-two female Sprague-Dawley rats were randomly divided into groups of sham-operated (SHAM), ovariectomised control (OVC), ovariectomised+60 mg kg -1 tocotrienol-rich fraction (OV+T) and ovariectomised+64.5 μg kg -1 of premarin ® (OV+ERT). The rats were treated for two months and the serum osteocalcien and serum C-telopeptide of type 1 collagen (CTX) were measured using ELISA technique, while the femoral dynamic changes were analysed histomorphometric ally. The CTX levels were found to be lowered compared to the pre-treatment levels for all the groups. Only the osteocalcin level of OV+ERT group was significantly reduced compared to its pre-treatment level. Dynamic histomorphometric analysis showed that both the OV+ERT and OV+T groups have lower single-labeled surface/bone surface (sLS) but higher double-labeled surface/bone surface (dLS), bone formation rate/bone surface (BFR) and mineral apposition rate (MAR) compared to the BC and OVC groups. The OV+T group showed better effects on most of the dynamic parameters compared to the OV+ERT group. Therefore, in postmenopausal osteoporosis model, tocotrienol-rich fraction has shown better bone protective effects than ERT.

AB - The standard treatment for postmenopausal osteoporosis is Estrogen Replacement Therapy (ERT) but it was associated with serious adverse effects such as breast cancer and cardiovascular disease. There is a need to find other alternatives for the treatment of post-menopausal osteoporosis. Vitamin E especially tocotrienol was shown to have anti-osteoporosis effects in many animal osteoporotic models but it has never been compared to estrogen. This study aimed to compare the effects of tocotrienol-enriched fraction to estrogen on the bone biochemical markers and dynamic histomorphometric changes using ovariectomised rats as the postmenopausal osteoporosis model. Thirty-two female Sprague-Dawley rats were randomly divided into groups of sham-operated (SHAM), ovariectomised control (OVC), ovariectomised+60 mg kg -1 tocotrienol-rich fraction (OV+T) and ovariectomised+64.5 μg kg -1 of premarin ® (OV+ERT). The rats were treated for two months and the serum osteocalcien and serum C-telopeptide of type 1 collagen (CTX) were measured using ELISA technique, while the femoral dynamic changes were analysed histomorphometric ally. The CTX levels were found to be lowered compared to the pre-treatment levels for all the groups. Only the osteocalcin level of OV+ERT group was significantly reduced compared to its pre-treatment level. Dynamic histomorphometric analysis showed that both the OV+ERT and OV+T groups have lower single-labeled surface/bone surface (sLS) but higher double-labeled surface/bone surface (dLS), bone formation rate/bone surface (BFR) and mineral apposition rate (MAR) compared to the BC and OVC groups. The OV+T group showed better effects on most of the dynamic parameters compared to the OV+ERT group. Therefore, in postmenopausal osteoporosis model, tocotrienol-rich fraction has shown better bone protective effects than ERT.

KW - Bone biomarkers

KW - Estrogen-deficiency

KW - Histomorphometry

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=84855959739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855959739&partnerID=8YFLogxK

U2 - 10.3923/ajava.2012.225.234

DO - 10.3923/ajava.2012.225.234

M3 - Article

AN - SCOPUS:84855959739

VL - 7

SP - 225

EP - 234

JO - Asian Journal of Animal and Veterinary Advances

JF - Asian Journal of Animal and Veterinary Advances

SN - 1683-9919

IS - 3

ER -